City Therapeutics
Develops next-generation RNAi therapeutics and engineering platform for multiple disease areas
$99.5MSeries B
Role not disclosedNV
NYBC Ventures
Activity from announced rounds
Activity in this selectionnrw-venture-f5757e51
- Rounds participated in
- 2
- Confirmed lead rounds
- — 2 roles undisclosed
- New companies
- 2 First participation on record · 0 follow-on
- Funding in participating rounds
- $169.5M 2 disclosed · full round size, not this investor’s share